Posted by Michael Wonder on 12 Sep 2022
PHARMAC simplifies criteria for COVID-19 anti-viral treatments
12 September 2022 - PHARMAC has confirmed today that it is simplifying the access criteria for the three anti-viral treatments it funds for treating early COVID-19.
From Wednesday 14 September 2022, the number of people who can access these treatments will more than double.
